Saceda-Corralo, D., Dominguez-Santas, M., Vano-Galvan, S. and Grimalt, R. (2022) What’s New in Therapy for Male Androgenetic Alopecia? American Journal of Clinical Dermatology.
https://doi.org/10.1007/s40257-022-00730-y

has been cited by the following article:

• TITLE: Androgens/Androgen Receptor in the Management of Skin Diseases

  AUTHORS: Xiaoyu Zhou, Yu Jiao, Wenqiang Zhang, Wenhai Li

  KEYWORDS: Androgens, Androgen Receptor, Skin Diseases

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.10 No.12, December 27, 2022

  ABSTRACT: Beyond regulation of male sexual function, the increasing evidence shows that androgens and androgen receptor (AR) have a variety of physiological and pathological effects on the skin. Skin cells express all androgen metabolizing enzymes that are required for independent skin androgen synthesis and the development of hyperandrogenic related disorders such as acne, hirsutism and androgenetic alopecia. Targeting various elements of androgen function and metabolism is the major goal of medication design for the treatment of androgen-related diseases. Antiandrogen drugs such as clascoterone, flutamide could improve conditions. Even though the involvement of androgens and AR in skin diseases has been investigated for a long time, their molecular mechanisms in skin disorders remain largely insufficient. In this review, recent studies and advances on the role of androgens/AR in several skin-related diseases and their therapeutics are systematically summarized.